These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6175175)

  • 1. Activation of factor XII in rat plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1981 Jul; 49(1):43-51. PubMed ID: 6175175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of factor XII in human plasma: protection by benzamidine of the cofactor function of high molecular weight kininogen.
    Briseid K; Johansen HT
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):344-52. PubMed ID: 6685967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextran-induced lowering of plasminogen proactivator and functionally active high molecular weight kininogen in the rat.
    Berstad J; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1982 May; 50(5):342-9. PubMed ID: 6180597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    EspaƱa F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
    Schmaier AH; Farber A; Schein R; Sprung C
    J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of factor XII in plasma from rats pretreated with tranexamic acid. Inhibition of a plasmin-induced loss of the functional activity of high molecular weight kininogen.
    Briseid K; Ryssdal AB
    Acta Pharmacol Toxicol (Copenh); 1980 Sep; 47(3):161-70. PubMed ID: 6449829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran-induced lowering of prekallikrein proactivator and prekallikrein in rat plasma.
    Briseid G; Briseid K; Toverud EL; Kristoffersen J
    Acta Pharmacol Toxicol (Copenh); 1978 Feb; 42(2):93-102. PubMed ID: 580160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
    Goldsmith GH
    J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact activation factors in plasma from women using oral contraceptives--increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein.
    Hoem NO; Johannesen S; Hauge G; Rud AC; Sandem S; Briseid K
    Thromb Res; 1991 Nov; 64(4):427-34. PubMed ID: 1788829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).
    Chan JY; Burrowes CE; Movat HZ
    Agents Actions; 1978 Jan; 8(1-2):65-72. PubMed ID: 636957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.